Page last updated: 2024-09-05

troleandomycin and triazolam

troleandomycin has been researched along with triazolam in 5 studies

Compound Research Comparison

Studies
(troleandomycin)
Trials
(troleandomycin)
Recent Studies (post-2010)
(troleandomycin)
Studies
(triazolam)
Trials
(triazolam)
Recent Studies (post-2010) (triazolam)
56926231,27538590

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez, FJ; Kronbach, T; Mathys, D; Meyer, UA; Umeno, M1
Bensimon, G; Bergougnan, L; Berlin, I; Danjou, P; Lamiable, D; Puech, AJ; Warot, D1
Asanome, K; Hosokawa, M; Ishii, I; Kitada, M; Kurose, Y; Nakasa, H; Ohmori, S1
Counihan, M; Duan, SX; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Shader, RI; von Moltke, LL; Wright, CE1
Greenblatt, DJ; Harmatz, JS; Hesse, LM; Richert, C; von Moltke, LL; Weemhoff, JL1

Trials

2 trial(s) available for troleandomycin and triazolam

ArticleYear
Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation.
    European journal of clinical pharmacology, 1987, Volume: 32, Issue:4

    Topics: Adult; Drug Interactions; Humans; Kinetics; Liver; Male; Memory; Psychomotor Performance; Triazolam; Troleandomycin

1987
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:3

    Topics: Administration, Oral; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Erythromycin; Humans; Hypnotics and Sedatives; In Vitro Techniques; Microsomes, Liver; Oxidoreductases, N-Demethylating; Time Factors; Triazolam; Troleandomycin

1998

Other Studies

3 other study(ies) available for troleandomycin and triazolam

ArticleYear
Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
    Molecular pharmacology, 1989, Volume: 36, Issue:1

    Topics: Animals; Autoantibodies; Cytochrome P-450 Enzyme System; DNA; Humans; Isoenzymes; Kinetics; Liver; Midazolam; Rats; Rats, Inbred Strains; Triazolam; Troleandomycin

1989
Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
    Biochimica et biophysica acta, 1998, May-08, Volume: 1380, Issue:3

    Topics: Adult; Animals; Aryl Hydrocarbon Hydroxylases; Catalysis; COS Cells; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; DNA, Complementary; Enzyme Activation; Genetic Vectors; Humans; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity; Testosterone; Transfection; Triazolam; Troleandomycin

1998
Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Enzyme Inhibitors; GABA Modulators; HIV Protease Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Isoenzymes; Ketoconazole; Lopinavir; Microsomes, Liver; Oxidoreductases, N-Demethylating; Pyrimidinones; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazolam; Troleandomycin

2003